Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Eur J Clin Nutr ; 60(11): 1253-7, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16721398

RESUMO

OBJECTIVE: To investigate the cholesterol-lowering effects of a low-fat cheese enriched with plant stanol esters in mildly hypercholesterolaemic subjects, as part of their normal diet. DESIGN: A randomized double-blind parallel-group study. SETTING: Valio Ltd, Helsinki. SUBJECTS: Sixty-seven mildly hypercholesterolaemic volunteers (24 men, 43 women) participated in the study, which all of them completed. INTERVENTIONS: The subjects were randomly assigned to the plant stanol ester group or the control group. During the 5-week intervention, the subjects in the stanol group consumed a cheese enriched with 2 g of plant stanols per day, and the subjects in the control group, a control cheese with no plant stanols. RESULTS: In the stanol ester group, as compared to the control group, both serum total and low-density lipoprotein (LDL) cholesterol decreased significantly, that is, by 5.8% (-0.32 mmol/l, 95% CI -0.50 to -0.15 mmol/l, P < 0.001) and 10.3% (-0.36 mmol/l, 95% CI -0.53 to -0.18 mmol/l, P < 0.001), respectively. There were no significant changes in high-density lipoprotein cholesterol (HDL), triglycerides or apolipoprotein B concentrations between the groups. CONCLUSION: Cheese enriched with 2 g of plant stanol in the form of fatty acid esters decreases serum total and LDL cholesterol significantly.


Assuntos
Anticolesterolemiantes/uso terapêutico , Alimentos Fortificados , Hipercolesterolemia/dietoterapia , Metabolismo dos Lipídeos/efeitos dos fármacos , Sitosteroides/uso terapêutico , Adulto , Idoso , Anticolesterolemiantes/farmacologia , Apolipoproteínas B/sangue , Queijo , Colesterol/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Método Duplo-Cego , Feminino , Humanos , Hipercolesterolemia/sangue , Masculino , Pessoa de Meia-Idade , Sitosteroides/farmacologia , Triglicerídeos/sangue
2.
J Physiol Pharmacol ; 57(2): 167-76, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16845223

RESUMO

The beneficial cardiovascular effects of soy protein have been studied intensively in recent years. Another protein-rich legume is lupin, which has been shown to have similar effects to those of soy in lowering serum cholesterol levels. In this study we compared the effects of lupin and soy protein on hypertension and vascular functions in spontaneously diabetic Goto-Kakizaki (GK) rat, which develop hypertension when fed a high-salt diet. The rats were fed with a 6% NaCl diet containing either lupin or soy protein isolate (20% weight/weight) for two weeks. In the end of the study the SBP was 18.6 mmHg lower (p<0.001) in the lupin group, and 12.0 mmHg lower (p<0.01) in the soy group than in the control group. Lupin and soy treatments normalised the decreased vasocontraction observed in the NaCl-fed control group, but only lupin treatment improved the impaired endothelium-dependent vasorelaxation. The attenuation of hypertension is likely to be mediated by the corrected vascular dysfunction, whose precise mechanism and the possible clinical relevance remains to be studied further.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Hipertensão/prevenção & controle , Lupinus/química , Proteínas de Plantas/farmacologia , Acetilcolina/farmacologia , Animais , Glicemia/metabolismo , Pressão Sanguínea/fisiologia , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/fisiopatologia , Relação Dose-Resposta a Droga , Endotélio Vascular/fisiopatologia , Hipertensão/sangue , Hipertensão/induzido quimicamente , Técnicas In Vitro , Lipídeos/sangue , Masculino , Artérias Mesentéricas/efeitos dos fármacos , Artérias Mesentéricas/fisiopatologia , Nitroprussiato/farmacologia , Norepinefrina/farmacologia , Proteínas de Plantas/administração & dosagem , Proteínas de Plantas/uso terapêutico , Ratos , Ratos Wistar , Cloreto de Sódio na Dieta/administração & dosagem , Cloreto de Sódio na Dieta/toxicidade , Proteínas de Soja/administração & dosagem , Proteínas de Soja/farmacologia , Proteínas de Soja/uso terapêutico , Vasoconstrição/efeitos dos fármacos , Vasoconstritores/farmacologia , Vasodilatadores/farmacologia
3.
Pediatr Infect Dis J ; 14(4): 270-8, 1995 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-7603807

RESUMO

To assess the value of adjunctive intravenous dexamethasone (DXM) and oral glycerol (GLY) for the treatment of bacteriologically proved bacterial meningitis, 122 infants and children with bacterial meningitis were randomly assigned to receive DXM intravenously (n = 32), GLY orally (n = 30), DXM plus GLY (n = 34) or neither (n = 26) of these drugs. All patients were treated with the same antimicrobial agent, ceftriaxone. The patients were followed neurologically for as long as 6 months. A thorough hearing evaluation was performed routinely 2 months or more after discharge from hospital. Overall 4 (7%) of the GLY-treated patients, compared with 11 (19%) of those not given GLY, developed audiologic or neurologic sequelae (P = 0.052), the relative risk of sequelae being 2.94 (95% confidence interval, 0.99 to 8.72). The patients who had received GLY showed less severe or profound bilateral hearing impairment than those not given GLY (0 vs. 7%, P = 0.049), and none of them had other neurologic abnormalities 3 or 6 months after discharge, compared with 5 (9%) of those not treated with GLY (P = 0.024). The DXM recipients showed only a tendency to less severe hearing impairment than those not given DXM. In conclusion oral GLY prevented neurologic sequelae in infants and children with bacterial meningitis more effectively than intravenous DXM.


Assuntos
Dexametasona/uso terapêutico , Glicerol/uso terapêutico , Transtornos da Audição/prevenção & controle , Meningites Bacterianas/tratamento farmacológico , Doenças do Sistema Nervoso/prevenção & controle , Administração Oral , Adolescente , Ceftriaxona/administração & dosagem , Ceftriaxona/uso terapêutico , Criança , Pré-Escolar , Intervalos de Confiança , Dexametasona/administração & dosagem , Quimioterapia Combinada , Feminino , Glicerol/administração & dosagem , Transtornos da Audição/etiologia , Humanos , Lactente , Injeções Intravenosas , Masculino , Meningites Bacterianas/complicações , Meningites Bacterianas/microbiologia , Meningites Bacterianas/mortalidade , Doenças do Sistema Nervoso/etiologia , Resultado do Tratamento
4.
J Hum Hypertens ; 18(11): 795-802, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15175633

RESUMO

Angiotensin-converting enzyme (ACE) is important in the regulation of blood pressure (BP). Two tripeptides that inhibit ACE, isoleucyl-prolyl-proline (Ile-Pro-Pro) and valyl-prolyl-proline (Val-Pro-Pro), have been isolated from certain sour milks. The aim of the study reported was to evaluate the effect on BP in subjects with mild hypertension of a new sour milk containing tripeptides. The initial number of subjects was 60 (36 men, 24 women). Among the criteria for inclusion in the study were systolic BP (SBP) between 140 and 180 mmHg and/or diastolic BP (DPB) between 90 and 110 mmHg, without antihypertensive drug therapy. There were two study periods with a washout period between. All subjects were given 1.5 dl per day of a placebo (regular sour milk) or of the active product, a milk that had been fermented with Lactobacillus helveticus bacteria and contained 2.4-2.7 mg of Ile-Pro-Pro and 2.4-2.7 mg of Val-Pro-Pro per 1.5 dl. In the first phase, SBP fell 16 mmHg from baseline in the active group, 2 mmHg more than in the placebo group (P=0.0668) and no difference in DBP (P=0.92). There was a statistically significant downward trend both in SBP and DBP (P=0.0001). During the second phase, SBP fell 11 mmHg in the active group (P=0.008). The reduction in SBP was significantly larger in active than placebo group (P=0.012). In the crossover analysis combining both phases, SBP fell on average 2.6+/-15.9 mmHg more on the active product compared with the placebo product, but this difference was not statistically significant (P=0.3111). The difference in DBP, 1.0+/-8.3 mmHg between the two test products was not significant either (P=0.4431). In conclusion, the ingestion of sour milk fermented by L. helveticus bacteria and that containing ACE inhibitory tripeptides seems to lower BP modestly.


Assuntos
Hipertensão/dietoterapia , Lactobacillus , Proteínas do Leite/administração & dosagem , Oligopeptídeos/administração & dosagem , Análise de Variância , Estudos Cross-Over , Feminino , Fermentação , Finlândia , Humanos , Masculino , Pessoa de Meia-Idade
5.
Ann Otol Rhinol Laryngol ; 89(4 Pt 1): 366-9, 1980.
Artigo em Inglês | MEDLINE | ID: mdl-7416687

RESUMO

On 100 pathological ears with tympanic membrane perforation, eustachian tube functions was measured by using sonotubometry and the negative pressure equalization test in an attempt to compare these two methods. The pressure equalization test did not appear to be a reliable tool for preoperative clinical determination of tube function because sonotubometry showed tubal opening in 85% (myringoplasty group) and in 49% (radical surgery group) of patholoical ears, which were not able to equalize negative middle ear pressure at all during swallowing. The negative pressure equalization test is considered to be unphysiological and may produce a locking phenomenon of the tube. Even a small negative pressure can act like a valve, producing an obstruction that muscle activity of the tube is no longer able to overcome particularly when mucosal changes are present in the tubal orifice. Sonotubometry is a physiological test and as such gives a reliable picture of the opening of the tube during swallowing. Data on tympanic aeration postoperatively will be reported later.


Assuntos
Otopatias/fisiopatologia , Tuba Auditiva/fisiopatologia , Membrana Timpânica , Adolescente , Adulto , Idoso , Criança , Otopatias/cirurgia , Orelha Média/cirurgia , Humanos , Pessoa de Meia-Idade , Pressão
6.
Acta Otolaryngol ; 103(3-4): 212-6, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3577752

RESUMO

Sonometric data on the Eustachian tube opening response to swallowing and to pressing the mandible down were evaluated in 51 normal ears and 62 ears with chronic disease. Testing with a narrow-band noise which was centered on 7 and 8 kHz gave the best results. The limit for a positive response was set at 3 dB, and of the normal ears, 80% showed a positive response in a short routine test. The data correlated reasonably well with surgical results. If test results point to tubal insufficiency, measures should be taken to prevent the formation of retraction pockets.


Assuntos
Estimulação Acústica , Tuba Auditiva/fisiologia , Adulto , Deglutição , Humanos , Mandíbula/fisiologia , Processo Mastoide/cirurgia , Ruído , Membrana Timpânica/cirurgia
7.
Acta Otolaryngol ; 103(5-6): 212-6, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-21449644

RESUMO

Sonometric data on the Eustachian tube opening response to swallowing and to pressing the mandible down were evaluated in 51 normal ears and 62 ears with chronic disease. Testing with a narrow-band noise which was centered on 7 and 8 kHz gave the best results. The limit for a positive response was set at 3 dB, and of the normal ears, 80% showed a positive response in a short routine test. The data correlated reasonably well with surgical results. If test results point to tubal insufficiency, measures should be taken to prevent the formation of retraction pockets.

8.
Acta Otolaryngol ; 90(5-6): 317-23, 1980.
Artigo em Inglês | MEDLINE | ID: mdl-7211325

RESUMO

The Eustachian tube function was tested preoperatively by sonotubometry and by the negative pressure equalization test in 87 ears subjected to simple myringoplasty, tympanoplasty alone, or tympanoplasty combined with mastoid surgery. The relations between tubal function test results and healing were analysed on average 10 months after the operation. The results indicating absent or partial pressure equalization ability were poorly correlated with the successful outcome of surgery, while sonotubometry showed a good correlation. Pressure equalization may produce such an unphysiological underpressure that many test results are erroneously negative. Sonotubometry is an entirely physiological method and has in this Department replaced the pressure equalization test for routine evaluation of the Eustachian tube function.


Assuntos
Tuba Auditiva/fisiologia , Timpanoplastia , Adolescente , Adulto , Idoso , Audiometria/instrumentação , Audiometria/métodos , Audiometria de Tons Puros , Criança , Pré-Escolar , Humanos , Processo Mastoide/cirurgia , Pessoa de Meia-Idade , Miringoplastia , Pressão , Prognóstico
9.
Acta Otolaryngol ; 99(1-2): 1-7, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-3976383

RESUMO

In a series of 120 patients with acoustic neurinoma, hearing preservation at removal of the tumour via the suboccipital approach was attempted in 30 ears. Hearing was preserved in 13 ears (43%), but in two, hearing was lost entirely in 3 to 4 years; thus the success rate was 36%. In 9 of the remaining 11 ears useful speech discrimination was present. Audiological tests showed increased retrocochlear loss after surgery. A surgical team should master the methods of both translabyrinthine and suboccipital surgery in order to choose the best approach for each patient.


Assuntos
Perda Auditiva Neurossensorial/prevenção & controle , Neuroma Acústico/cirurgia , Testes de Impedância Acústica , Audiometria de Resposta Evocada , Audiometria de Tons Puros , Audiometria da Fala , Limiar Auditivo , Testes Calóricos , Nervo Coclear/lesões , Perda Auditiva Bilateral/prevenção & controle , Humanos , Neuroma Acústico/diagnóstico por imagem , Complicações Pós-Operatórias/prevenção & controle , Reflexo Acústico , Tomografia Computadorizada por Raios X
10.
Acta Otolaryngol ; 108(3-4): 184-9, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2816334

RESUMO

Users of a single-channel intracochlear implant (CI, n = 10) (3M/House), a single-channel vibrotactile aid (V, n = 8) (Minivib 3/Special Instrument Ab) and acoustic hearing aids (HA, n = 9) were tested. The comparison was made after training and a minimum of 11 months' use of the devices. All subjects were considered profoundly deaf, but the HA group had some residual hearing. The HA group achieved the best mean test scores in all the tests given. The difference between the CI group and V group increased, in favour to the CI users, as the auditory task was changed from the level of simple signal analysis to the level of linguistic interpretation.


Assuntos
Implantes Cocleares , Surdez/reabilitação , Auxiliares de Audição , Adulto , Audiometria de Tons Puros , Desenho de Equipamento , Humanos , Pessoa de Meia-Idade , Testes de Discriminação da Fala
11.
Acta Otolaryngol ; 86(3-4): 233-40, 1978.
Artigo em Inglês | MEDLINE | ID: mdl-707066

RESUMO

In the diagnosis of acoustic neuromata the stapedial reflex test, the forward vs reverse Békésy test, the loudness balance test, and the adaptation test have all been found superior among the special tests used in predicting a tumour diagnosis. Conventional X-ray studies of the internal acoustic meati are always performed, followed by tomograms and in suspected cases by meatocisternography. In the present series translabyrinthine total removal was performed in 21 cases, a planned decompression in 5, while in 2 the removal was subtotal. Only two permanent facial paralyses arose, one corrected by masseteric plasty and the other by facial-hypoglossal lateral perceptive hearing impairment as being caused by a tumour until proven otherwise.


Assuntos
Neoplasias dos Nervos Cranianos/diagnóstico , Neoplasias dos Nervos Cranianos/cirurgia , Neuroma Acústico/diagnóstico , Neuroma Acústico/cirurgia , Nervo Vestibulococlear , Adolescente , Adulto , Idoso , Audiometria , Criança , Meios de Contraste , Neoplasias dos Nervos Cranianos/diagnóstico por imagem , Paralisia Facial/etiologia , Humanos , Doença de Meniere/diagnóstico , Métodos , Pessoa de Meia-Idade , Neuroma Acústico/diagnóstico por imagem , Complicações Pós-Operatórias , Radiografia , Nervo Vestibulococlear/diagnóstico por imagem
12.
Acta Otolaryngol ; 88(1-2): 74-8, 1979.
Artigo em Inglês | MEDLINE | ID: mdl-474123

RESUMO

Results of vestibular neurectomy, total eighth nerve section, and saccus decompression in 42 patients with Meniere's disease are reported. Vestibular nerve section was found in isolated cases to be a very effective method of abolishing the symptom of vertigo. Hearing is not affected but may be lost owing to opening of the vertical canal or disruption of blood supply. Saccus surgery might be the surgical treatment of choice in early cases with good hearing but in patients with fixed non-fluctuating hearing loss, rehabilitation can be effected only by vestibular neurectomy. In bilateral cases either sac surgery or the use of vestibulotoxic drugs is advised.


Assuntos
Orelha Interna/cirurgia , Saco Endolinfático/cirurgia , Doença de Meniere/cirurgia , Nervo Vestibular/cirurgia , Nervo Vestibulococlear/cirurgia , Adulto , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade
13.
Eur J Clin Nutr ; 66(7): 843-9, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22617279

RESUMO

BACKGROUND/OBJECTIVES: Lactobacillus helveticus LBK-16H-fermented milk products containing tripeptides isoleucine-proline-proline and valine-proline-proline lower blood pressure in hypertensive subjects using office and home blood pressure registration. The present study was aimed to evaluate the effects of two doses of these lactotripeptides on 24-h ambulatory blood pressure and lipidomics profiles in mildly hypertensive subjects. SUBJECTS/METHODS: In a randomized, double-blind, placebo-controlled parallel group study, 89 mildly hypertensive subjects ingested, after a 1-month run-in period, a fermented milk drink with 5 mg per day of lactotripeptides during 3 months, and a milk drink with 50 mg per day of lactotripeptides for the following 3 months, or a placebo milk drink without lactotripeptides. Ambulatory blood pressure (24 h) was recorded at baseline and at the end of the intervention periods. Lipidomics profiles were characterized before and after the 6-month intervention. RESULTS: After the second intervention period (50 mg per day of lactotripeptides), systolic and diastolic 24-h blood pressures decreased significantly in the peptide, but not in the placebo group. However, the treatment effects -2.6 mm Hg (95% confidence interval (CI): -5.7 to 0.4) in systolic and -1.3 mm Hg (95% CI: -3.4 to 0.8) in diastolic blood pressure did not reach statistic significance. Ingestion of 5 mg per day of lactotripeptides for 3 months did not lower blood pressure. The peptide group was dominated by decrease in multiple phospholipids (PL). CONCLUSIONS: Ingestion of fermented milk with daily dose of 50 mg of lactotripeptides appears to lower elevated blood pressure slightly from the baseline, but not significantly compared with the placebo group and to induce significant decreases in multiple PL.


Assuntos
Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Produtos Fermentados do Leite/química , Hipertensão/tratamento farmacológico , Oligopeptídeos/uso terapêutico , Fosfolipídeos/sangue , Adulto , Anti-Hipertensivos/farmacologia , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/etiologia , Produtos Fermentados do Leite/metabolismo , Produtos Fermentados do Leite/microbiologia , Método Duplo-Cego , Feminino , Humanos , Hipertensão/sangue , Lactobacillus helveticus , Masculino , Pessoa de Meia-Idade , Oligopeptídeos/farmacologia , Fatores de Risco
14.
Eur J Clin Nutr ; 64(4): 424-31, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20145666

RESUMO

BACKGROUND: The milk casein-derived biologically active tripeptides, isoleucyl-prolyl-proline (Ile-Pro-Pro) and valyl-prolyl-proline (Val-Pro-Pro), have documented antihypertensive effect probably related to reduced angiotensin formation. It has been suggested that these tripeptides may reduce arterial stiffness and improve endothelial function. Our aim was to evaluate whether the milk-based drink containing Ile-Pro-Pro and Val-Pro-Pro influence arterial stiffness, measured as augmentation index (AIx), and endothelial function in man. METHODS: In a double-blind parallel group intervention study, 89 hypertensive subjects received daily peptide milk containing a low dose of tripeptides (5 mg/day) for 12 weeks and a high dose (50 mg/day) for the following 12 weeks, or a placebo milk drink to titrate the dose-response effect. Arterial stiffness was assessed by pulse wave analysis at the beginning and end of each intervention period. Endothelial function was tested by examining pulse wave reflection response to sublingual nitroglycerin and salbutamol inhalation. Blood pressure was measured by using office and 24-h ambulatory blood pressure measurement. RESULTS: At the end of the second intervention period, AIx decreased significantly in the peptide group compared with the placebo group (peptide group -1.53% (95% confidence interval (CI) -2.95 to -0.12), placebo group 1.20% (95% CI 0.09-2.32), P=0.013). No change in endothelial function index was observed (peptide group 0.02 (95% CI -0.06 to 0.08), placebo group 0.04 (95% CI -0.04 to 0.12), P=0.85). There were no statistically significant differences between the effects of the peptide and placebo treatment on office and 24-h ambulatory blood pressure. CONCLUSIONS: Long-term treatment with Lactobacillus helveticus-fermented milk containing bioactive peptides reduces arterial stiffness expressed as AIx in hypertensive subjects.


Assuntos
Anti-Hipertensivos/farmacologia , Endotélio Vascular/efeitos dos fármacos , Hipertensão/tratamento farmacológico , Lactobacillus helveticus , Leite/química , Oligopeptídeos/farmacologia , Adulto , Animais , Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Caseínas/química , Caseínas/metabolismo , Método Duplo-Cego , Feminino , Fermentação , Microbiologia de Alimentos , Humanos , Hipertensão/metabolismo , Masculino , Pessoa de Meia-Idade , Leite/metabolismo , Leite/microbiologia , Oligopeptídeos/uso terapêutico , Artéria Radial
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA